|
|
| (8 intermediate revisions by the same user not shown) |
| Line 1: |
Line 1: |
| | __NOTOC__ |
| {{Infobox_Disease | | | {{Infobox_Disease | |
| Name = Calciphylaxis | | | Name = Calciphylaxis | |
| Line 12: |
Line 13: |
| MeshNumber = C18.452.174.130.186 | | | MeshNumber = C18.452.174.130.186 | |
| }} | | }} |
| {{Search infobox}} | | {{Calciphylaxis}} |
| {{CMG}} | | {{CMG}} |
|
| |
|
| | ==[[Calciphylaxis overview|Overview]]== |
|
| |
|
| | ==[[Calciphylaxis historical perspective|Historical Perspective]]== |
|
| |
|
| '''Calciphylaxis''' is a syndrome of vascular calcification and [[skin]] [[necrosis]]. It is seen exclusively in patients with end stage [[renal disease]]. It results in chronic non-healing wounds and requires parathyroidectomy and hyperbaric therapy. Calciphylaxis is a rare but serious disease.
| | ==[[Calciphylaxis pathophysiology|Pathophysiology]]== |
|
| |
|
| ==What is it?== | | ==[[Calciphylaxis causes|Causes]]== |
|
| |
|
| Calciphylaxis is characterised by | | ==[[Calciphylaxis differential diagnosis|Differentiating Calciphylaxis from other Diseases]]== |
|
| |
|
| # systemic medial calcification of the arteries, i.e. calcification of [[tunica media]]. Unlike other forms of vascular calcifications (eg, intimal, medial, valvular), calciphylaxis is characterised also by
| | ==[[Calciphylaxis epidemiology and demographics|Epidemiology and Demographics]]== |
| # small vessel mural calcification with or without endovascular fibrosis, extravascular calcification and vascular thrombosis, leading to tissue ischaemia (including skin ischaemia and, hence, skin [[necrosis]]).
| |
|
| |
|
| The cause is not known. It does not seem to be an immune type reaction. In other words, calciphylaxis is not only a hypersensitivity reaction (= allergic reaction) leading to sudden local calcification. Clearly, additional factors are involved in calciphylaxis. It possibly could be described as calcific uraemic arteriolopathy.
| | ==[[Calciphylaxis risk factors|Risk Factors]]== |
|
| |
|
| Calciphylaxis is one type of extraskeletal calcification. Similar extraskeletal calcifications are observed in some patients with hypercalcaemic states, including patients with milk alkali syndrome, sarcoidosis, primary hyperparathyroidism, and hypervitaminosis D.
| | ==[[Calciphylaxis natural history, complications and prognosis|Natural History, Complications and Prognosis]]== |
| | |
| ==Who is affected?== | |
| | |
| Calciphylaxis most commonly occurs in patients with end-stage [[renal disease]] who are on [[hemodialysis]] or who have recently received a [[renal transplant]] ([[kidney transplant]]). Yet, calciphylaxis does not occur only in end-stage [[renal disease]] patients. It also has been reported in patients with [[breast cancer]] (treated with [[chemotherapy]]), liver [[cirrhosis]] (due to [[alcohol]] abuse), cholangiocarcinoma, [[Crohn's disease]], [[rheumatoid arthritis]] ([[RA]]), and [[systemic lupus erythematosus]] ([[SLE]]) (including [[SLE]] patients with or without [[chronic renal disease]]).
| |
|
| |
|
| ==Diagnosis== | | ==Diagnosis== |
| | | [[Calciphylaxis history and symptoms|History and Symptoms]] | [[Calciphylaxis physical examination|Physical Examination]] | [[Calciphylaxis biopsy|Biopsy]] |
| There is no diagnostic test for calciphylaxis. The diagnosis is a clinical one. The characteristic lesions are the ischaemic skin lesions (usually with areas of skin necrosis). They should alert the physician or nurse.
| |
| | |
| The necrotic skin lesions (i.e., the dying or already dead skin areas) typically appear as violaceous (dark bluish purple) lesions and/or completely black leathery lesions. They can be extensive.
| |
| | |
| The suspected diagnosis can be confirmed by a skin [[biopsy]]. It shows arterial calcification and occlusion in the absence of [[vasculitis]].
| |
| | |
| ==Treatment== | | ==Treatment== |
| | | [[Calciphylaxis medical therapy|Medical Therapy]] | [[Calciphylaxis surgery|Surgery]] | [[Calciphylaxis prevention|Prevention]] | [[Calciphylaxis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Calciphylaxis future or investigational therapies|Future or Investigational Therapies]] |
| The optimal treatment is prevention. Rigorous and continuous control of phosphate and calcium balance most probably will avoid the metabolic changes which may lead to calciphylaxis.
| | ==Case Studies== |
| | | [[Calciphylaxis case study one|Case #1]] |
| There is no specific treatment. Of the treatments that exist, none is internationally recognised as the standard of care. An acceptable treatment could include:
| |
| | |
| *[[Dialysis]] (the number of sessions may be increased)
| |
| *Intensive wound care
| |
| *Adequate pain control
| |
| *Correction of the underlying plasma calcium and phosphorus abnormalities (lowering the Ca x P product below 55 mg2/dL2)
| |
| *Avoiding (further) local tissue trauma (including avoiding all subcutaneous injections, and all not-absolutely-necessary infusions and transfusions)
| |
| *Urgent parathyroidectomy: The efficacy of this measure remains uncertain although calciphylaxis is associated with frank hyperparathyroidism. Urgent parathyroidectomy may benefit those patients who have uncontrollable plasma calcium and phosphorus concentrations despite dialysis. Also, [[cinacalcet]] can be used and may serve as an alternative to parathyroidectomy. The trade name of [[cinacalcet]] is [[Sensipar]] or [[Mimpara]].
| |
| *Patients who receive [[kidney transplant]]s also receive [[immunosuppression]]. Considering lowering the dose of or discontinuing the use of immunosuppressive drugs in renal transplant patients who continue to have persistent or progressive calciphylactic skin lesions can contribute to an acceptable treatment of calciphylaxis.
| |
| | |
| ==Response to treatment== | |
| | |
| Unfortunately, response to treatment is not guaranteed. Also, the necrotic skin areas may get infected, and this then may lead to [[sepsis]] (ie, infection of blood with bacteria; sepsis can be life-threatening) in some patients. Overall, the clinical prognosis remains poor.
| |
| | |
| ==Who to contact?==
| |
| | |
| The correct person to ask questions about calciphylaxis is a nephrology fellow or a professor of nephrology.
| |
|
| |
|
| ==External links== | | ==External links== |
| * [http://content.nejm.org/cgi/content/full/357/13/1326?query=TOC "Images in Clinical Medicine: Calciphylaxis with Arterial Calcification", from "The New England Journal of Medicine] | | * [http://content.nejm.org/cgi/content/full/357/13/1326?query=TOC "Images in Clinical Medicine: Calciphylaxis with Arterial Calcification", from "The New England Journal of Medicine] |
| * [http://www.dermnet.org.nz/systemic/calciphylaxis.html DermNet NZ: Calciphylaxis] | | * [http://www.dermnet.org.nz/systemic/calciphylaxis.html DermNet NZ: Calciphylaxis] |
| * [https://www2.kumc.edu/calciphylaxisregistry/ Calciphylaxis Registry]
| | |
| {{clr}}
| | [[Category:Disease]] |
| [[Category:Dermatology]] | | [[Category:Dermatology]] |
| [[Category:Nephrology]] | | [[Category:Nephrology]] |